International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

PsoProtect Registry Data Update

psoprotect_update_615

PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes the first 1,652 cases. Below is a summary of the data collected or view the full report on the PsoProtect website.

Average age: 48 years
Phenotype of psoriasis: 1,605 plaque psoriasis, 47 pustular psoriasis
Average BMI: 27.7 kg/m2
Average number of days of symptoms from COVID-19: 10 days

Cases reported by country of assessment (≥20 cases):

PsoProtect 6-15-22_country

Severity of psoriasis at time of onset of COVID-19 (PGA):

PsoProtect 6-15-22_severity

Hospitalization required due to COVID-19:

PsoProtect 6-15-22_hospital

In addition to demographics, PsoProtect collects the following types of de-identified data:

  • Psoriasis disease characteristics, comorbidities and systemic treatment for psoriasis at onset of COVID-19
  • COVID-19 characteristics and disease course
  • COVID-19 outcome

We encourage clinicians to continue reporting cases of COVID-19 (suspected or confirmed) in psoriasis via the simple online PsoProtect case report form.

*Data are preliminary and include a limited number of cases and should not be used to inform clinical decision making

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Categories

Tags

Recent Posts

Blog -Expert Insights-Choon-Graphic

The Future of Treatment in Generalized Pustular Psoriasis

Blog -Expert Insights-Maskin-Graphic

Access to Biologics in Argentina: Rethinking Time to PASI 90

Blog Post - Psoriasis Hub

IPC Partners with Scientific Education Support to Create New Psoriasis and Psoriatic Arthritis Hub

Also Read

Carle Paul

Focus on Psoriasis: A Report from the European Academy of Dermatology and Venereology 31st Annual Congress (EADV)

The European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the parole “Designing the Future of Dermatology and Venereology.” The event took place from September 7 – 10, 2022, as a hybrid meeting with the option of attending virtually or in person. The following congress report includes fifteen summaries of presentations focusing on psoriasis. You can download the full report or read the summary.

Read More
World Psoriasis Day 2022 Graphic
mental health

2022 World Psoriasis Day

The IPC is a proud supporter of World Psoriasis Day by uniting for action with IFPA to advance care and change the perception of psoriatic disease. Watch the video below to hear IPC’s key opinion leaders from around the world discuss this year’s theme – psoriasis and its impact on mental health.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.